💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Genocea Biosciences, Inc. (GNCA)
« Back to company indexGNCA Chatter Timeline
Stock Ticker for GNCA
Most Active Tweeters for GNCA
| User | Tweets |
|---|---|
| @SeekingAlpha | 2 |
| @otcdynamics | 1 |
| @SiteFocusHQ | 1 |
| @PropThinker | 1 |
| @stock_titan | 1 |
Recent Tweets for GNCA
 |
@intratio $GNCA https://t.co/2AgW4BYm2J Genocea Biosciences Inc The automated equity analyst has predicted this equity value… https://t.co/cBknm0NQ6a August 2nd 2021, 6:08am |
 |
@CSIMarket $GNCA #StockMarket #GenoceaBiosciences released second quarter of 2021 earnings season Earnings on… https://t.co/ZsoNKOPQmK July 30th 2021, 9:07pm |
 |
@SiteFocusHQ $GNCA Earnings Intelligence Analysis of recent earnings identified Genocea Biosciences, Inc. (GNCA) business focus… https://t.co/X8MnXFZJ4G July 29th 2021, 10:07pm |
 |
@SeekingAlpha $GNCA - Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2021 Results - Earnings Call Transcript.… https://t.co/LEwpXzUC2O July 29th 2021, 9:07pm |
|
@SeekingAlpha $GNCA - Genocea Biosciences, Inc. 2021 Q2 - Results - Earnings Call Presentation. https://t.co/dQ0u1X3AD9 #trading #business #investing July 29th 2021, 4:07pm |
 |
@EdgarInsider New Form 8-K [Press/News Current Report] entry filed by $GNCA $GGNNW GENOCEA BIOSCIENCES, INC. GENOCEA BIOSCIENCE… https://t.co/o2uEvo8WOr July 29th 2021, 12:07pm |
 |
@Market_Newswire $GNCA SEC Filing: 8-K Earnings - GENOCEA BIOSCIENCES, INC. (0001457612) July 29 undefined July 29th 2021, 12:07pm |
 |
@sbwcws Genocea expects cash, cash equivalents to fund operations to the end of 2022 $GNCA July 29th 2021, 11:07am |
 |
@StockPods $GNCA Earnings Call Today: 8:30 AM EST Webcast: https://t.co/hxyQkBcN4U Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 July 29th 2021, 10:07am |
 |
@PropThinker $GNCA finally dosing patients with GEN-11. Good to see company get through long needle-to-needle & manufacturing p… https://t.co/ZFOQXwqmSl July 23rd 2021, 2:07pm |
 |
@otcdynamics $GNCA Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast https://t.co/lCiaplCeEA July 22nd 2021, 9:07pm |
 |
@StckPro $GNCA NEW ARTICLE : Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast… https://t.co/BltuwAKg5T July 22nd 2021, 9:07pm |
 |
@FlashAlert_me $GNCA [15s. delayed]: Issued Press Release on July 22, 17:05:00: Genocea to Host Second Quarter 2021 Corporate Upda… https://t.co/XdnBpEMFCC July 22nd 2021, 9:07pm |
 |
@StockNewsBot2 $GNCA Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast https://t.co/1CW9dRp5aA July 22nd 2021, 9:07pm |
 |
@newsfilterio Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast $GNCA https://t.co/t5aJYY6Q5g July 22nd 2021, 9:07pm |
 |
@stock_titan $GNCA Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast https://t.co/OiL3L3LXzF July 22nd 2021, 9:07pm |
 |
@WALLSTREETODDS_ $GNCA Out of the 1325 other times GNCA was up 1.4% during a trading day, 60% of the time it traded lower by the sa… https://t.co/KvCGtdv0nf July 16th 2021, 5:07pm |
 |
@Jiantkwazi @Alexand80831564 $GNCA another but without much conviction for me. July 14th 2021, 10:07pm |
|
@WALLSTREETODDS_ $GNCA Out of the 1317 other times GNCA was up 1.4% during a trading day, 60% of the time it traded lower by the sa… https://t.co/pkfsVFlnQG July 14th 2021, 7:07pm |
 |
@Dansgamepokei RT @DansGamePoker: $GNCA one of my favorite set ups. 500 shares in 4.71 out 6.32 right out of the first halt. 34% roi +$800 for the morning… July 14th 2021, 10:07am |
|
@intratio $GNCA https://t.co/2AgW4BYm2J Genocea Biosciences Inc Our AI estimates that this stock s value should remain flat i… https://t.co/o3cxUKYuta July 14th 2021, 10:07am |
 |
@Gambiste1 RT @1stOncology: #Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for #GEN011 #NeoantigenTargeted #TCellTherapy $GNCA https:… July 14th 2021, 8:07am |
 |
@1stOncology #Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for #GEN011 #NeoantigenTargeted #TCellTherapy $GNCA https://t.co/DJVHhn7F9g July 14th 2021, 8:07am |
|
@newsfilterio Genocea Biosciences Starts Dosing In Mid-Stage GEN-011 Study In Solid Tumors $GNCA https://t.co/NxxHGgym7m July 13th 2021, 7:07pm |
 |
@GaIn01544213 RT @VTMtrading: Genocea doses first patient in Phase 1/2a TiTAN clinical trial for GEN-011 $GNCA July 13th 2021, 6:07pm |
 |
@SmallCapsDaily $GNCA Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Therapy… https://t.co/sDPlbRNVVk July 13th 2021, 3:07pm |
 |
@quantisnow $GNCA ? Genocea Biosciences, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits https://t.co/ZyuQnJxnNx July 13th 2021, 12:07pm |
|
@EdgarInsider Filing for 8-K [Press/News Current Report] has been made with the SEC: $GNCA $GGNNW GENOCEA BIOSCIENCES, INC https://t.co/rsns20SBKT July 13th 2021, 12:07pm |
|
@FlashAlert_me $GNCA [15s. delayed] filed form 8-K on July 13, 08:46:24 https://t.co/JNoeUQTsHV July 13th 2021, 12:07pm |
 |
@JJ_BIO_MAX RT @otcdynamics: $GNCA Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Therapy https:… July 13th 2021, 12:07pm |
|
@WALLSTREETODDS_ $GNCA Out of the 476 other times GNCA was up 5.3% during a trading day, 59% of the time it traded lower by the sam… https://t.co/G3lBrV4iJG July 13th 2021, 12:07pm |
|
@otcdynamics $GNCA Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Therapy https://t.co/qsSL1UhKuT July 13th 2021, 11:07am |
|
@newsfilterio Genocea doses first patient in early-stage GEN-011 cancer study $GNCA https://t.co/par11kpNl7 July 13th 2021, 11:07am |
 |
@VTMtrading Genocea doses first patient in Phase 1/2a TiTAN clinical trial for GEN-011 $GNCA July 13th 2021, 11:07am |
 |
@MarketCurrents $GNCA - Genocea doses first patient in early-stage GEN-011 cancer study https://t.co/KO0AGMcBQA July 13th 2021, 11:07am |
|
@FlashAlert_me $GNCA [15s. delayed]: Issued Press Release on July 13, 07:30:00: Genocea Doses First Patient in Phase 1/2a TiTAN Cl… https://t.co/bTZiSkwViU July 13th 2021, 11:07am |
|
@StockNewsBot2 $GNCA Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Therapy https://t.co/i5s6IxU24M July 13th 2021, 11:07am |
|
@quantisnow $GNCA ? Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Thera… https://t.co/wHTOG3fa4c July 13th 2021, 11:07am |
|
@stock_titan $GNCA Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Therapy… https://t.co/MU9tYK2wBB July 13th 2021, 11:07am |
|
@WALLSTREETODDS_ $GNCA Out of the 614 other times GNCA was up 4.3% during a trading day, 60% of the time it traded lower by the nex… https://t.co/jy7GLFTVVi July 12th 2021, 3:07am |
 |
@DansGamaPoker The play I liked the most today was on $GNCA. Took 10k shares in at 2.74 avg, out at 3.10. I was going for surge in… https://t.co/0aDVFjNIQh July 10th 2021, 3:07am |
|
@WALLSTREETODDS_ $GNCA Out of the 614 other times GNCA was up 4.3% during a trading day, 60% of the time it traded lower by the nex… https://t.co/ZhiFnglHwX July 10th 2021, 1:07am |
 |
@Beeken_health $GNCA - Is the Options Market Predicting a Spike in Genocea (GNCA) Stock? https://t.co/39nMnaGlR6 https://t.co/XxPY9Koszl July 7th 2021, 1:07pm |
|
@WALLSTREETODDS_ $GNCA Out of the 1114 other times GNCA was up 2.2% during a trading day, 59% of the time it traded lower by the sa… https://t.co/Ucq3DoYxJ4 July 6th 2021, 12:07pm |
 |
@PolackSki Genocea insiders adding more, again. Five Form 4’s today. $GNCA https://t.co/GeHwz8vrB2 https://t.co/5L5UPqkLG3 July 2nd 2021, 4:07pm |
|
@FlashAlert_me $GNCA [15s. delayed] filed SEC form 4: Director Schwab Gisela: Transacted Derivative Securities on 2021-07-01. https://t.co/zajWztXrJl July 2nd 2021, 4:07pm |
|
@FlashAlert_me $GNCA [15s. delayed] filed SEC form 4: Director BATE KENNETH: Transacted Derivative Securities on 2021-07-01. https://t.co/xPkwWAK69I July 2nd 2021, 3:07pm |
|
@FlashAlert_me $GNCA [15s. delayed] filed SEC form 4: Director Bosley Katrine: Transacted Derivative Securities on 2021-07-01. https://t.co/pmErGR4ZzG July 2nd 2021, 3:07pm |
|
@quantisnow $GNCA ? SEC Form 4 filed by Higgins Michael J https://t.co/wnM6pV2y7j 15s delayed. July 2nd 2021, 3:07pm |
|
@FlashAlert_me $GNCA [15s. delayed] filed SEC form 4: Director Higgins Michael J: Transacted Derivative Securities on 2021-07-01. https://t.co/NIIancMa9R July 2nd 2021, 3:07pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?